MANCHESTER, UK – Myconostica, a Manchester UK-based medical diagnostic company which specialises in rapid and highly specific tests for life-threatening fungal infections, has completed the third close of a $10.8 million round of financing with a $2 million investment from the UMIP Premier Fund. The company is building a South Carolina facility. (more…)
Greenville, SC: Selah Technologies, an advanced materials
manufacturer, announced today that it has closed on a $1.5 million Series A private financing round. This funding will enable the company to make considerable strides in the commercialization of its two core platform nanomaterials technologies, Selah DotsTM and Selah TubesTM. (more…)
DURHAM, N.C. – Proventys, Inc., a personalized medicine knowledge service provider, announced today that it secured $5.65M in Series A1 financing. Life sciences-focused venture capital firm Burrill & Company led the investment in Proventys. Timothy Thompson, formerly managing director of business development (mergers and acquisitions) at Aetna, joined
the company as president and CEO. (more…)
Atlanta, GA– GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta- based HIV/AIDS vaccine development company, has entered into a $10 million common stock purchase agreement with Fusion Capital Fund II of Chicago. (more…)
Atlanta, GA- Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, announced today that it has selected ten semifinalists in its second annual BIO/Plan Competition. (more…)
Blacksburg, VA: Intrexon Corporation, a privately held life sciences company focused on biotherapeutic control systems, announced today it has closed a $25 million Series C-2 financing by New River Management V, LP, a private investment fund managed by Third Security, LLC. Previous rounds of investment have been provided by New River Management IV,LP, New River Management V and NewVa Capital Partners, LP, a regional investment partnership. Funds and other entities managed by Third Security have invested a total of $56.5 million in Intrexon to date. (more…)
Cary, North Carolina and Lexington, Massachusetts– Critical
Therapeutics, Inc. (NASDAQ: CRTX) and Cornerstone BioPharma Holdings, Inc., a privately-held company, today announced the signing of a definitive merger agreement. (more…)
